Department of Diagnostic and Interventional Radiology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Medical Physics, Department of Diagnostic and Interventional Radiology, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
JCO Clin Cancer Inform. 2024 Apr;8:e2300231. doi: 10.1200/CCI.23.00231.
Body composition (BC) may play a role in outcome prognostication in patients with gastroesophageal adenocarcinoma (GEAC). Artificial intelligence provides new possibilities to opportunistically quantify BC from computed tomography (CT) scans. We developed a deep learning (DL) model for fully automatic BC quantification on routine staging CTs and determined its prognostic role in a clinical cohort of patients with GEAC.
We developed and tested a DL model to quantify BC measures defined as subcutaneous and visceral adipose tissue (VAT) and skeletal muscle on routine CT and investigated their prognostic value in a cohort of patients with GEAC using baseline, 3-6-month, and 6-12-month postoperative CTs. Primary outcome was all-cause mortality, and secondary outcome was disease-free survival (DFS). Cox regression assessed the association between (1) BC at baseline and mortality and (2) the decrease in BC between baseline and follow-up scans and mortality/DFS.
Model performance was high with Dice coefficients ≥0.94 ± 0.06. Among 299 patients with GEAC (age 63.0 ± 10.7 years; 19.4% female), 140 deaths (47%) occurred over a median follow-up of 31.3 months. At baseline, no BC measure was associated with DFS. Only a substantial decrease in VAT >70% after a 6- to 12-month follow-up was associated with mortality (hazard ratio [HR], 1.99 [95% CI, 1.18 to 3.34]; = .009) and DFS (HR, 1.73 [95% CI, 1.01 to 2.95]; = .045) independent of age, sex, BMI, Union for International Cancer Control stage, histologic grading, resection status, neoadjuvant therapy, and time between surgery and follow-up CT.
DL enables opportunistic estimation of BC from routine staging CT to quantify prognostic information. In patients with GEAC, only a substantial decrease of VAT 6-12 months postsurgery was an independent predictor for DFS beyond traditional risk factors, which may help to identify individuals at high risk who go otherwise unnoticed.
体成分(BC)可能在胃食管腺癌(GEAC)患者的预后预测中发挥作用。人工智能为从计算机断层扫描(CT)扫描中机会性地定量 BC 提供了新的可能性。我们开发了一种深度学习(DL)模型,用于对常规分期 CT 进行全自动 BC 定量,并在 GEAC 患者的临床队列中确定其预后作用。
我们开发并测试了一种 DL 模型,用于对常规 CT 上定义的 BC 测量值进行量化,这些测量值包括皮下和内脏脂肪组织(VAT)和骨骼肌,并使用基线、3-6 个月和 6-12 个月的术后 CT 调查了它们在 GEAC 患者队列中的预后价值。主要结局是全因死亡率,次要结局是无病生存率(DFS)。Cox 回归评估了(1)基线时 BC 与死亡率之间的关联,以及(2)基线和随访扫描之间 BC 下降与死亡率/DFS 之间的关联。
模型性能很高,Dice 系数≥0.94±0.06。在 299 名 GEAC 患者(年龄 63.0±10.7 岁;19.4%为女性)中,中位随访 31.3 个月后有 140 例死亡(47%)。在基线时,没有 BC 测量值与 DFS 相关。只有在 6-12 个月的随访后,VAT 显著下降>70%与死亡率(风险比 [HR],1.99 [95%置信区间,1.18 至 3.34]; =.009)和 DFS(HR,1.73 [95%置信区间,1.01 至 2.95]; =.045)相关,独立于年龄、性别、BMI、国际抗癌联盟分期、组织学分级、切除状态、新辅助治疗以及手术和随访 CT 之间的时间。
DL 能够从常规分期 CT 中机会性地估计 BC,以量化预后信息。在 GEAC 患者中,只有在手术后 6-12 个月时 VAT 显著下降,是传统危险因素之外的 DFS 的独立预测因子,这可能有助于识别否则未被注意到的高危个体。